Suchergebnisse - "Okada, Annabelle A"

PubPharm (19)

1

Short-term results for brolucizumab in treatment-naïve neovascular age-related macular degeneration : a Japanese multicenter study

enthalten in: Japanese journal of ophthalmology | 2022

von Tanaka, K. | Koizumi, H. | Tamashiro, T. | +21

2

Subfoveal choroidal thickness after brolucizumab therapy for neovascular age-related macular degeneration : a short-term multicenter study

enthalten in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie | 2022

von Tamashiro, T. | Tanaka, K. | Itagaki, K. | +18

3

Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in the ALTAIR Study : 96-Week Outcomes in the Polypoidal Choroidal Vasculopathy Subgroup

enthalten in: Advances in therapy | 2022

von Okada, A. | Takahashi, K. | Ohji, M. | +44

4

Short-term results for brolucizumab in treatment-naïve neovascular age-related macular degeneration: a Japanese multicenter study

enthalten in: Japanese journal of ophthalmology | 2022

von Tanaka, K. | Koizumi, H. | Tamashiro, T. | +21

5

Short-term results for brolucizumab in treatment-naïve neovascular age-related macular degeneration: a Japanese multicenter study

enthalten in: Japanese journal of ophthalmology | 2022

von Tanaka, K. | Koizumi, H. | Tamashiro, T. | +21

6

Short-term results for brolucizumab in treatment-naïve neovascular age-related macular degeneration: a Japanese multicenter study

enthalten in: Japanese journal of ophthalmology | 2022

von Tanaka, K. | Koizumi, H. | Tamashiro, T. | +21

7

Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in the ALTAIR Study: 96-Week Outcomes in the Polypoidal Choroidal Vasculopathy Subgroup

enthalten in: Advances in therapy | 2022

von Okada, A. | Takahashi, K. | Ohji, M. | +3

8

Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in the ALTAIR Study: 96-Week Outcomes in the Polypoidal Choroidal Vasculopathy Subgroup

enthalten in: Advances in therapy | 2022

von Okada, A. | Takahashi, K. | Ohji, M. | +3

9

Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in the ALTAIR Study: 96-Week Outcomes in the Polypoidal Choroidal Vasculopathy Subgroup

enthalten in: Advances in therapy | 2022

von Okada, A. | Takahashi, K. | Ohji, M. | +3

10

Subfoveal choroidal thickness after brolucizumab therapy for neovascular age-related macular degeneration: a short-term multicenter study

enthalten in: Graefe's archive for clinical and experimental ophthalmology | 2022

von Tamashiro, T. | Tanaka, K. | Itagaki, K. | +17